Who
Brett A. Grimaud
SVP, Gen Counsel and Secretary
Company insider
Files Form 4 as: SVP, Gen Counsel and Secretary, Theravance Biopharma.
In numbers
- Trades disclosed
- 29
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Feb 2023
- Last trade
- 23 Sep 2026
- Last filed
- 24 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Sep 2026filed 24 Sep 2026 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code D | —223,917 | filing |
| 23 Sep 2026filed 24 Sep 2026 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code D | —107,812 | filing |
| 23 Sep 2026filed 24 Sep 2026 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code D | —23,439 | filing |
| 23 Sep 2026filed 24 Sep 2026 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code D | —223,917 | filing |
| 23 Sep 2026filed 24 Sep 2026 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code D | —107,812 | filing |
| 23 Sep 2026filed 24 Sep 2026 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code D | —23,439 | filing |
| 20 Aug 2026filed 24 Aug 2026 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code F | $135K7,952 at $16.95 | filing |
| 20 Aug 2026filed 24 Aug 2026 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code F | $135K7,952 at $16.95 | filing |
| 20 May 2026filed 22 May 2026 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code F | $146K8,829 at $16.55 | filing |
| 20 May 2026filed 22 May 2026 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code F | $146K8,829 at $16.55 | filing |
| 1 Apr 2026filed 3 Apr 2026 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code F | $410K20,833 at $19.66 | filing |
| 20 Feb 2026filed 24 Feb 2026 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code F | $410K20,833 at $19.66 | filing |
| 20 Nov 2025filed 24 Nov 2025 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code F | $341K19,024 at $17.90 | filing |
| 20 Aug 2025filed 22 Aug 2025 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code F | $131K9,762 at $13.39 | filing |
| 20 May 2025filed 22 May 2025 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code F | $92K9,743 at $9.45 | filing |
| 28 Feb 2025filed 4 Mar 2025 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 20 Feb 2025filed 24 Feb 2025 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code F | $140K14,534 at $9.66 | filing |
| 20 Nov 2024filed 22 Nov 2024 | Theravance BiopharmaPharmaceuticals | SEC FORM 4 Code F | $92K9,268 at $9.97 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.